5 research outputs found

    Body weight and survival rate of mice following lethal challenge with influenza virus.

    No full text
    <p>At 18 days following the last immunization, all mice in study group B were intranasally challenged with 10 LD<sub>50</sub> of H1N1/A/TN/1-560/2009-MA2 virus. (A) Body weight and (B) survival of mice orally immunized with PBS, LL-HA1/L/AcmA or HA1/L/AcmA, or subcutaneously immunized with HA1/L/AcmA-FA, was monitored daily for 14 days following virus challenge. The body weight of mice on the day of viral challenge was used as the baseline weight to determine the body weight changes post-viral challenge. Asterisks indicate statistically significant differences in comparison with the PBS-treated group (*p<0.05; **p<0.01; ***p<0.001).</p

    Binding optimization of HA1/L/AcmA recombinant protein to <i>L</i>. <i>lactis</i>.

    No full text
    <p>(A) The percentage of <i>L</i>. <i>lactis</i> surface displaying HA1/L/AcmA recombinant protein after incubation with different amounts of HA1/L/AcmA recombinant protein. (B) The percentage of <i>L</i>. <i>lactis</i> surface displaying HA1/L/AcmA recombinant protein after incubation with HA1/L/AcmA recombinant protein for 1 h, 2 h, 3 h, and 4 h, respectively. (C) The percentage and mean fluorescence intensity (MFI) value of <i>L</i>. <i>lactis</i> surface displaying HA1/L/AcmA recombinant protein after incubation with HA1/L/AcmA recombinant protein in GM17 and PBS, respectively. The data represents mean ± standard deviation. Asterisk indicates statistically significant differences between groups (**P<0.01).</p
    corecore